Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Initial implantation
March 2019
SHARING OPTIONS:

HANNOVER, Germany—Implandata Ophthalmic Products GmbH shared recently that it had successfully implanted its novel eye pressure sensor in the first patient in its ARGOS-SC01 clinical study. This study is evaluating the EYEMATE-SC sensor implant, which is placed suprachoroidally, as a means of continuous intraocular pressure monitoring for glaucoma. This device is earmarked for patients who have not yet reached the point of cataract surgery.
 
“This breakthrough product enables glaucoma patients for the first time to monitor their own eye pressure at any point in time. I expect that it will improve therapeutic compliance and also significantly reduce the risk of unnecessary visual field loss or even blindness due to glaucoma,” said Prof. Peter Szurman of the Eye Clinic Sulzbach, Knappschaft Hospital Saar, principal investigator for the trial.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.